IPP Bureau
Enko advances Enkompass platform through DNA-encoded library technology
By IPP Bureau - June 16, 2022
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
Lupin Diagnostics launches its first regional reference lab in Patna
By IPP Bureau - June 16, 2022
Expanding diagnostics footprint in East India
Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India
By IPP Bureau - June 16, 2022
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation
By IPP Bureau - June 16, 2022
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA
By IPP Bureau - June 16, 2022
With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development
80% of hypertensive women found to be obese: Study
By IPP Bureau - June 16, 2022
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
QIAGEN selects TCS for cloud transformation strategy
By IPP Bureau - June 16, 2022
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Apollo Hospitals completes a procedure using new technology SENTINEL
By IPP Bureau - June 16, 2022
Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.
EPR-Technologies announces new approach to emergency care when CPR fails
By IPP Bureau - June 16, 2022
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
CytoSMART introduces ML algorithm for organoid analysis
By IPP Bureau - June 16, 2022
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
Merck KGaA collaborates with University of Bonn to advance molecular machine learning
By IPP Bureau - June 15, 2022
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
Dr. Reddy's Lab launches sorafenib tablets in US
By IPP Bureau - June 15, 2022
Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.
Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa
By IPP Bureau - June 15, 2022
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Piramal Pharma expands API capabilities at Digwal
By IPP Bureau - June 15, 2022
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Eurocine Vaccines expands portfolio with a therapeutic HSV-2 vaccine candidate
By IPP Bureau - June 15, 2022
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
